ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION FOR TREATING IRRITABLE BOWEL SYNDROME, CONTAINING INTESTINAL PERISTALSIS CONTROLLER, AGENT PREVENTING DELAY OF GASES, AND DIGESTIVE ENZYMES, AND PREPARATION METHOD THEREOF Russian patent published in 2016 - IPC A61K31/24 A61K31/80 A61K38/43 A61K9/16 A61K9/20 A61K47/00 A61J3/10 A61P1/00 

FIELD: pharmaceutics.

SUBSTANCE: group of inventions refers to pharmaceutics. Described is pharmaceutical composition, adapted for oral administration in form of tablet, film-coated tablet or capsule. Above composition is used for preventing or treating irritable bowel syndrome, including repeated gastrointestinal discomfort or pain at least for three days a month during last three months, associated with two or more following states: a) improved with defecation, b) occurrence is connected with change of frequency of faeces, and c) occurrence is connected with change of stool appearance, where discomfort relates to unpleasant filling not described as pain. Said pharmaceutical composition consists of trimebutine or its pharmaceutically acceptable salt, simetikone, α-D-galactosidase, binding agent, diluent, absorbing agent, disintegrating agent, lubricating means and means of facilitating sliding. Also described is method of producing said composition and use of said composition.

EFFECT: invention provides implementation of above application.

23 cl